Alteration of activator protein 1 DNA binding activity in gentamicin-induced hair cell degeneration

A Albinger-Hegyi1, I Hegyi, I Nagy

  • 1Department of Oto-Rhino-Laryngology, Head and Neck Surgery, University Hospital Zürich, Frauenklinikstr. 24, 8091 Zurich, Switzerland.

Neuroscience
|December 13, 2005
PubMed

Insights

Gentamicin exposure activates the Jun N-terminal kinase pathway in cochlear hair cells, leading to increased activating protein-1 binding activity. This response, mediated by c-Fos, is transient and specific to hair cells, offering insights into ototoxicity mechanisms.

Area of Science:

  • Ototoxicity research
  • Cellular signaling pathways
  • Auditory neuroscience

Background:

  • Sensorineural hearing loss stems from cochlear hair cell or auditory neuron damage.
  • Aminoglycoside drugs, like gentamicin, are known ototoxic agents causing hair cell damage.
  • Mitogen-activated protein kinase (MAPK) signaling, particularly Jun N-terminal kinases (JNKs), is implicated in aminoglycoside-induced ototoxicity.

Purpose of the Study:

  • To investigate the downstream effects of gentamicin on JNK signaling in cochlear hair cells.
  • To identify specific transcription factors activated by gentamicin-induced JNK signaling.
  • To determine the cellular localization and temporal profile of these molecular events.

Main Methods:

  • Organ of Corti explants from rats were treated with gentamicin.
  • Electrophoretic mobility shift assays (EMSAs) were used to assess activating protein-1 (AP-1) binding activity.
  • Western blotting or similar techniques were likely used to identify protein components of AP-1 complexes.

Main Results:

  • Gentamicin treatment significantly increased AP-1 binding activity in rat organ of Corti explants.
  • The primary component of the induced AP-1 complexes was identified as the c-Fos protein.
  • The observed AP-1 induction was transient and occurred specifically within the hair cells.

Conclusions:

  • Gentamicin ototoxicity involves the activation of the JNK-AP-1 signaling pathway in cochlear hair cells.
  • c-Fos is a key mediator in the AP-1 response to gentamicin in these cells.
  • Understanding this transient, hair cell-specific pathway is crucial for developing therapeutic strategies against aminoglycoside-induced hearing loss.

Related Concept Videos

Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...